BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24002440)

  • 1. Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound.
    Raza SA; Jang HJ; Kim TK
    Abdom Imaging; 2014 Feb; 39(1):153-61. PubMed ID: 24002440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
    Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
    Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.
    Tarantino L; Ambrosino P; Di Minno MN
    World J Gastroenterol; 2015 Aug; 21(32):9457-60. PubMed ID: 26327753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of portal vein thrombosis discontinued with liver tumors in patients with liver cirrhosis and tumors by contrast-enhanced US: a pilot study.
    Song ZZ; Huang M; Jiang TA; Zhao QY; Yao L; Mou Y; Zhao JK; Ao JY; Chen F; Chen Y
    Eur J Radiol; 2010 Aug; 75(2):185-8. PubMed ID: 19464131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Role of Contrast-enhanced Ultrasound in the Discrimination of Malignant Portal Vein Thrombosis in Patients With Hepatocellular Carcinoma.
    Kwon JH; Yoo SH; Nam SW; Lee YJ; Shin YR
    Anticancer Res; 2020 Aug; 40(8):4351-4363. PubMed ID: 32727763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-energy CT with iodine quantification in distinguishing between bland and neoplastic portal vein thrombosis in patients with hepatocellular carcinoma.
    Ascenti G; Sofia C; Mazziotti S; Silipigni S; D'Angelo T; Pergolizzi S; Scribano E
    Clin Radiol; 2016 Sep; 71(9):938.e1-9. PubMed ID: 27241866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis.
    Chen J; Zhu J; Zhang C; Song Y; Huang P
    Eur Radiol; 2020 May; 30(5):2871-2880. PubMed ID: 32020403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma: Diagnostic Accuracy of Gadoxetic Acid-enhanced MR Imaging.
    Kim JH; Lee JM; Yoon JH; Lee DH; Lee KB; Han JK; Choi BI
    Radiology; 2016 Jun; 279(3):773-83. PubMed ID: 26780538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of imaging characteristics between hepatic benign regenerative nodules and hepatocellular carcinomas associated with Budd-Chiari syndrome by contrast enhanced ultrasound.
    Zhang R; Qin S; Zhou Y; Song Y; Sun L
    Eur J Radiol; 2012 Nov; 81(11):2984-9. PubMed ID: 22341409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of portal vein tumor thrombosis in quantitative perfusion analysis of contrast-enhanced ultrasound of hepatocellular carcinoma.
    Wang Z; Liu G; Lu MD; Xie X; Kuang M; Wang W; Xu Z; Lin M; Chen L
    Ultrasound Med Biol; 2015 May; 41(5):1277-86. PubMed ID: 25623820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-mode and contrast enhanced ultrasound guided biopsy of portal vein thrombosis. Value in the diagnosis of occult hepatocellular carcinoma in liver cirrhosis.
    Sparchez Z; Radu P; Zaharia T; Kacso G; Diaconu B; Grigorescu I; Badea R
    Med Ultrason; 2010 Dec; 12(4):286-94. PubMed ID: 21210013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis.
    Ahn JH; Yu JS; Cho ES; Chung JJ; Kim JH; Kim KW
    Korean J Radiol; 2016; 17(4):533-40. PubMed ID: 27390544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver.
    Quaia E; De Paoli L; Angileri R; Cabibbo B; Cova MA
    Eur J Radiol; 2014 Mar; 83(3):456-62. PubMed ID: 24387826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation.
    Piscaglia F; Gianstefani A; Ravaioli M; Golfieri R; Cappelli A; Giampalma E; Sagrini E; Imbriaco G; Pinna AD; Bolondi L;
    Liver Transpl; 2010 May; 16(5):658-67. PubMed ID: 20440775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Malignant Portal Vein Thrombosis with Contrast-Enhanced Ultrasonography.
    Chammas MC; Oliveira AC; D Ávilla MJ; Moraes PH; Takahashi MS
    Ultrasound Med Biol; 2019 Jan; 45(1):50-55. PubMed ID: 30366607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonographic characterisation of hepatocellular carcinoma at time of diagnosis.
    Ignee A; Weiper D; Schuessler G; Teuber G; Faust D; Dietrich CF
    Z Gastroenterol; 2005 Mar; 43(3):289-94. PubMed ID: 15765302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma.
    Rossi S; Ghittoni G; Ravetta V; Torello Viera F; Rosa L; Serassi M; Scabini M; Vercelli A; Tinelli C; Dal Bello B; Burns PN; Calliada F
    Eur Radiol; 2008 Aug; 18(8):1749-56. PubMed ID: 18369630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients.
    Sorrentino P; D'Angelo S; Tarantino L; Ferbo U; Bracigliano A; Vecchione R
    World J Gastroenterol; 2009 May; 15(18):2245-51. PubMed ID: 19437565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.